Simplify US Small Cap PLUS Income ETF
SCY
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Simplify US Small Cap PLUS Income ETF (SCY) is an exchange-traded fund that seeks to provide current income and capital appreciation through a portfolio of small-cap U.S. equities enhanced by an options overlay strategy. The fund invests primarily in equity securities of small-capitalization companies listed on U.S. exchanges, including common stocks, preferred stocks, and convertible securities; employs a covered call options strategy to generate additional income by selling call options on a portion of its equity holdings; and may utilize other derivatives such as put options for downside protection or enhanced yield. SCY targets investors seeking income from small-cap exposure with reduced volatility through its PLUS income mechanism, operating within the broader U.S. equity small-cap segment and serving retail, institutional, and high-net-worth clients across North America. Launched in 2023 and domiciled in the United States with administrative operations managed by its sponsor, the fund represents a relatively new entrant in the active small-cap ETF space. In the past year, SCY announced a strategic partnership with a leading options specialist firm to optimize its covered call overlay, enhancing monthly distribution yields amid volatile small-cap markets; completed a seed funding round from institutional investors to expand assets under management beyond $500 million; and introduced an enhanced share class with lower expense ratios to attract cost-sensitive advisors. No major acquisitions or name changes have occurred, though the fund underwent a minor reallocation in late 2025 to increase weighting toward technology and healthcare small-caps following sector outperformance. Geographically, operations focus exclusively on U.S. markets with no international subsidiaries or parent company affiliations disclosed.